Intercept Pharmaceuticals, Inc.

Rockefeller Capital Management L.P.

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

1,037,763

Value ($000)

19,240

Weight

0.1%

2020 Q1 - 2023 Q3 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	19,240	0.1%	1,037,763	9/30/2023
2023 Q2	8/14/2023	8,598	0.0%	777,402	6/30/2023
2023 Q1	5/16/2023	9,877	0.0%	735,488	3/31/2023
2022 Q4	3/6/2023	6,991	0.0%	565,185	12/31/2022
2022 Q3	11/2/2022	7,487	0.0%	536,764	9/30/2022
2022 Q2	8/12/2022	7,177	0.0%	519,722	6/30/2022
2022 Q1	5/13/2022	7,961	0.0%	489,352	3/31/2022
2021 Q4	2/14/2022	6,326	0.0%	388,350	12/31/2021
2021 Q3	11/12/2021	5,006	0.0%	337,141	9/30/2021
2021 Q2	8/10/2021	3,564	0.0%	178,488	6/30/2021
2021 Q1	5/11/2021	4	0.0%	200	3/31/2021
2020 Q4	2/12/2021	4	0.0%	200	12/31/2020
2020 Q3	11/13/2020	8	0.0%	200	9/30/2020
2020 Q2	8/12/2020	10	0.0%	200	6/30/2020
2020 Q1	5/12/2020	13	0.0%	200	3/31/2020